FX

AUD/JPY is accumulating gains in the Asian session. However, gains seem limited in the vicinity of 84.70. Neutral momentum oscillators ask for a wait-and-watch approach. The AUD/JPY cross maintains the previous day’s gains and looks to refresh the daily high near 84.70 in the Asian session.  At the time of writing, AUD/JPY is trading at
0 Comments
Commodity supercycle gathers momentum – What’s next for prices [Video] Commodity prices are booming across the board with everything from metals, energy to agriculture markets, trading near multi-year highs. Last week, Palladium, Iron Ore, and Lumber prices took center-stage skyrocketing to all-time record highs. Meanwhile, Copper and Aluminium prices hit 10-year highs. Both metals have
0 Comments
Silver takes offers to refresh intraday low, prints four-day downtrend. Sustained break of monthly support line, downbeat RSI favor sellers. Three-week-old horizontal support, 200-SMA test the bears, falling trend line from April 21 adds to the upside filters. Silver extends the last week’s downside break of the monthly support line, now resistance, while taking offers
0 Comments
Equities give up some ground on Friday but remain poised for fresh records. Earnings season continues to see record growth in earnings Fed remains committed to full employment and a fully accommodative stance. Another week another set of fresh records for equity markets. There really is no alternative (TINA) continues to dominate the narrative. The
0 Comments
Goldman Sachs cites risks, both upside and downside, to China’s economic recovery amid chatters of strong rebound after the coronavirus (COVID-19) pandemic, as well as ahead of April’s official PMI. The bank expects 8.5% read GDP for 2021 while citing Beijing’s strong run-up after the covid-led economic shock. The piece cites “potential for stronger-than-expected exports”
0 Comments
NASDAQ:OCGN fell by 3.86% on Wednesday as its rocky week of trading continued. Ocugen obtained rights to sell a COVID-19 vaccine candidate in the United States. Covaxin is already available in India, where the COVID-19 vaccine has taken a turn for the worse. NASDAQ:OCGN has had an incredible run since December of 2020 when it
0 Comments